During the past decade, New Orleans Cancer Institute at Memorial Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Orleans Cancer Institute at Memorial Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 2 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Orleans Cancer Institute at Memorial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New Orleans Cancer Institute at Memorial Medical Center" are "Leukemia" (2 trials), "Breast Cancer" (1 trials), "Head and Neck Cancer" (1 trials), "Lung Cancer" (1 trials) and "Malignant Mesothelioma" (1 trials). Many other conditions were trialed in "New Orleans Cancer Institute at Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "New Orleans Cancer Institute at Memorial Medical Center" are "Drug" (6 trials), "Biological" (4 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "AC regimen" (1 trials), "Accelerated fractionation radiation therapy" (1 trials), "Alemtuzumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Orleans Cancer Institute at Memorial Medical Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "New Orleans Cancer Institute at Memorial Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in New Orleans Cancer Institute at Memorial Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Orleans Cancer Institute at Memorial Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".